Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)

SHE:002872 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	284.93	270.42	192.71	278.25	338.68	291.73
Short-Term Investments	-	-	-	-	-	40
Trading Asset Securities	-	-	-	-	82	-
Cash & Short-Term Investments	284.93	270.42	192.71	278.25	420.68	331.73
Cash Growth	14.52%	40.32%	-30.74%	-33.86%	26.81%	-7.71%
Accounts Receivable	106.44	158.01	181.16	195.01	240.01	581.25
Other Receivables	156.57	159.58	170.94	186.77	80.85	61.17
Receivables	263.01	317.59	352.11	381.78	320.87	642.43
Inventory	104.92	106.8	136.22	130.87	124.58	288.58
Other Current Assets	15.8	7.63	10	25.18	54.08	48.19
Total Current Assets	668.65	702.44	691.04	816.08	920.21	1,311
Property, Plant & Equipment	1,435	1,464	1,581	1,613	1,638	1,761
Long-Term Investments	42.8	43.39	50.25	52.46	50	13.53
Goodwill	-	-	-	-	-	3.64
Other Intangible Assets	280.26	285.9	311.77	319.5	327.14	368.72
Long-Term Deferred Tax Assets	79.3	77.58	68.07	64.97	69.15	97.81
Long-Term Deferred Charges	20.61	23.4	16.33	11.74	14.51	27.49
Other Long-Term Assets	133.71	139.07	92.43	92.64	101.44	62.88
Total Assets	2,660	2,736	2,811	2,971	3,120	3,646
Accounts Payable	41.8	46.47	77.34	55.31	126.45	297.18
Accrued Expenses	11.77	14.34	10.28	25.27	14.52	14.8
Short-Term Debt	93.27	80.28	117.34	89.59	132.42	395.55
Current Portion of Long-Term Debt	23.99	49.5	82.98	143.45	49.59	-
Current Portion of Leases	0.8	0.83	1.62	2.18	2.71	-
Current Income Taxes Payable	0.45	0.53	0.46	3.19	0.5	1.55
Current Unearned Revenue	29.25	23.36	38.42	46.73	25.65	14.61
Other Current Liabilities	117.42	144.01	126.12	189.68	120.72	185.97
Total Current Liabilities	318.74	359.31	454.55	555.39	472.55	909.66
Long-Term Debt	242.89	234.54	118.8	89.65	219.42	190.71
Long-Term Leases	2.55	2.45	4.84	4.3	9.65	-
Long-Term Unearned Revenue	110.35	115.42	127.79	126.34	131.46	150.97
Long-Term Deferred Tax Liabilities	4.06	4.07	4.47	2.84	2.81	1.09
Other Long-Term Liabilities	3.24	6	4.8	4.54	4.9	3.8
Total Liabilities	681.83	721.8	715.25	783.06	840.79	1,256
Common Stock	318	318	318	318	318	318
Additional Paid-In Capital	1,401	1,401	1,401	1,401	1,401	1,401
Retained Earnings	244.01	280.72	368.12	461.2	551.76	619.57
Comprehensive Income & Other	7.02	6.18	4.58	2.8	2.89	2.01
Total Common Equity	1,970	2,006	2,091	2,183	2,273	2,340
Minority Interest	8.44	8.64	4.18	4.82	5.81	49.35
Shareholders' Equity	1,978	2,014	2,096	2,188	2,279	2,390
Total Liabilities & Equity	2,660	2,736	2,811	2,971	3,120	3,646
Total Debt	363.49	367.61	325.58	329.17	413.78	586.26
Net Cash (Debt)	-78.56	-97.19	-132.86	-50.92	6.89	-254.53
Net Cash Per Share	-0.25	-0.31	-0.42	-0.16	0.02	-0.80
Filing Date Shares Outstanding	318	318	318	318	318	318
Total Common Shares Outstanding	318	318	318	318	318	318
Working Capital	349.91	343.12	236.49	260.69	447.65	401.27
Book Value Per Share	6.19	6.31	6.58	6.86	7.15	7.36
Tangible Book Value	1,690	1,720	1,780	1,863	1,946	1,968
Tangible Book Value Per Share	5.31	5.41	5.60	5.86	6.12	6.19
Buildings	1,696	1,676	1,663	1,420	1,402	1,176
Machinery	547.54	535.34	533.41	516.98	520.48	506.6
Construction In Progress	16.95	33.8	81.96	291.84	252.61	655.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.